Background
Although contralateral C7 (CC7) transfer has been widely used for treating traumatic brachial plexus injury, the procedure safety is questionable. We performed a systematic review to investigate the donor-site morbidity including sensory abnormality and motor deficit to guide clinical decision-making.
Methods
A systematic review on CC7 transfer for traumatic brachial plexus injury was performed for the original articles in PubMed and EMBASE databases. Patient demographic data and donor-site morbidity of CC7 transfer including incidence, recovery rate and time were extracted from the included studies. The sensory abnormality areas and muscles involved in motor weakness were also summarized.
Results
A total 904 patients from 27 studies were reviewed. Overall, 74% of patients (668/897) experienced sensory abnormalities, and 98% of patients (618/633) recovered to normal; the mean recovery time was 3 months. For motor function, 20% of patients (118/592) had motor deficit after CC7 transfer and 91% (107/117) regained normal motor functions; mean recovery time was 6 months. Sensory abnormality mainly happened in the median innervated area of the hand, whereas motor deficit most often involved radial nerve innerved muscles. There were 2% of patients (19/904) with long-term morbidity of donor site in the studies.
Conclusions
The incidence of donor-site morbidity after CC7 transfer was relatively high, and severe and long-term defects occurred occasionally. CC7 transfer should be indicated only when other donor nerves are not available, and with a comprehensive knowledge of the potential risks.
Level of evidence
Level III